[{"uuid": "57409b07-d2fd-3bf3-b594-5b2ca0dd6e55", "title": "Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edwards-lifesciences-host-earnings-conference-120500048.html", "providerPublishTime": 1738670700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RnsKL5NlExGK7.MGJgnuFg--~B/aD00ODA7dz0zOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9c0ceeafbea0deb2aecd4c8721d1a040", "width": 392, "height": 480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ODNCfi5V2nKvmq5BOq9j3g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9c0ceeafbea0deb2aecd4c8721d1a040", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "ab54a1ab-323b-36a7-bf6c-318de16642d5", "title": "Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/calculating-intrinsic-value-edwards-lifesciences-130010899.html", "providerPublishTime": 1738414810, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "5a7d3be6-be9b-3274-b3e8-826e3f22d73c", "title": "Edwards Lifesciences Corporation (EW): A Bull Case Theory", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/edwards-lifesciences-corporation-ew-bull-201422093.html", "providerPublishTime": 1738354462, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bf7XC8lGREzIH.pqQ0dzTA--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/37df51ea04636c36d95d254e12edd403", "width": 768, "height": 430, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/jS8WvvBBTblFePC7D4RU4A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/37df51ea04636c36d95d254e12edd403", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "5d9a7bfa-38d0-3432-98f9-59dd83e7d84a", "title": "Top Analyst Reports for Alibaba, Airbnb & Royal Caribbean Cruises", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/top-analyst-reports-alibaba-airbnb-234500157.html", "providerPublishTime": 1738280700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/unB.G3w8oi9jKPA.MYFFAA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/27128fdf68f183170008538bbd9e5400", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.dbbPP44ZA63uh4vGaCe_A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/27128fdf68f183170008538bbd9e5400", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABNB", "BABA", "RCL", "EW", "LLY"]}, {"uuid": "65f4ef72-2648-3019-8db5-3a0c577b6af2", "title": "Edwards Lifesciences Is Poised For Solid Growth In 2025\u2014Analyst Highlights TAVR Growth, Margin Expansion", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/edwards-lifesciences-poised-solid-growth-192134571.html", "providerPublishTime": 1738264894, "type": "STORY", "relatedTickers": ["EW"]}, {"uuid": "e69d3d3f-1997-36f8-a726-5b3864dbd438", "title": "Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/edwards-lifesciences-q4-earnings-set-152100919.html", "providerPublishTime": 1738250460, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/4lmvToGK4d2FNc0SIOXMvw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9QlIKgTx3.4CceRjHKiKug--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "896e6444-0300-374e-9734-13a82a890c38", "title": "Stifel Upgrades Edwards Lifesciences to Buy From Hold, Adjusts Price Target to $90 From $75", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/stifel-upgrades-edwards-lifesciences-buy-111840128.html", "providerPublishTime": 1738235920, "type": "STORY", "relatedTickers": ["EW"]}, {"uuid": "2fedd120-0378-3665-a036-905a4d57aa48", "title": "Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/analysts-estimate-edwards-lifesciences-ew-150043661.html", "providerPublishTime": 1738076443, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bHsRpCKrGzzbaGHEolBtWw--~B/aD02MTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af", "width": 900, "height": 618, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6pxctapMeQGo6ifr3PxShQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW", "TMO"]}, {"uuid": "85634592-f366-36c8-9779-59e200786eae", "title": "What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/edwards-lifesciences-corporations-nyse-ew-130032945.html", "providerPublishTime": 1737637232, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "03c713a3-d87e-3a17-9fb7-d35f3950e16c", "title": "Masimo Taps Katie Szyman as Permanent CEO", "publisher": "The Wall Street Journal", "link": "https://finance.yahoo.com/m/03c713a3-d87e-3a17-9fb7-d35f3950e16c/masimo-taps-katie-szyman-as.html", "providerPublishTime": 1737498120, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Fwf5HL4GsEGPbDfR3MJBPg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 1200, "height": 630, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/zIJaagDuCJitt1Cvcwyc7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BDX", "EW", "MASI"]}, {"uuid": "ff0c6bce-01b9-36c0-9580-43e485701d0d", "title": "Edwards Lifesciences Insider Sold Shares Worth $343,736, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/edwards-lifesciences-insider-sold-shares-221141019.html", "providerPublishTime": 1737065501, "type": "STORY", "relatedTickers": ["EW"]}, {"uuid": "322e0758-8bc0-31d6-85c7-b7c8e3139b32", "title": "Edwards Lifesciences Shares Fall After Downgrade From Wolfe Research", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/edwards-lifesciences-shares-fall-downgrade-204032505.html", "providerPublishTime": 1737060032, "type": "STORY", "relatedTickers": ["EW"]}, {"uuid": "c1cbdee5-ac17-3784-865e-b149e1a97257", "title": "Declining Stock and Solid Fundamentals: Is The Market Wrong About Edwards Lifesciences Corporation (NYSE:EW)?", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/declining-stock-solid-fundamentals-market-140019294.html", "providerPublishTime": 1737036019, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "6e429192-cf0f-362a-88da-1144110eb20f", "title": "Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/believe-growth-prospects-edwards-lifesciences-131716078.html", "providerPublishTime": 1737033436, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QabcYs8N_ui6jFmgViUgBQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4e64478f3c197fd4496cff471c35c4ed", "width": 768, "height": 430, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/xBptkb6q1GUmkE.Tdh5o6A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4e64478f3c197fd4496cff471c35c4ed", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}, {"uuid": "19ffca20-211c-38a3-91bd-1c5745c483d4", "title": "Should Edwards Lifesciences Stock Stay in Your Portfolio Now?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/edwards-lifesciences-stock-stay-portfolio-122500230.html", "providerPublishTime": 1737030300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IYksUEF.ZX5JOPFmQ194jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW", "HAE"]}, {"uuid": "63ce50af-c4cb-36d3-b3d8-ec35d910cad9", "title": "Wolfe Research Downgrades Edwards Lifesciences to Underperform From Peer Perform, Price Target is $60", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/wolfe-research-downgrades-edwards-lifesciences-114734468.html", "providerPublishTime": 1737028054, "type": "STORY", "relatedTickers": ["EW"]}, {"uuid": "e4b7c18e-fcea-3665-ba7d-6d60f85bc944", "title": "Undervalued Small Caps With Insider Action In January 2025", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/undervalued-small-caps-insider-action-110743068.html", "providerPublishTime": 1737025663, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OB1nfJ1XGlebSq696rWQeQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/16016486ecb815bcffeea7a1908fff4e", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/bB5.p_7KUNS98U5vL_8T1g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/16016486ecb815bcffeea7a1908fff4e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW", "FPAR-A.ST", "FPAR-D.ST", "KEMPOWR.HE"]}, {"uuid": "fbc13d68-28c6-33fe-8f3a-b9c15d0981ef", "title": "Pulse Biosciences Names Paul LaViolette CEO", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/pulse-biosciences-names-paul-laviolette-135337263.html", "providerPublishTime": 1736517217, "type": "STORY", "relatedTickers": ["PLSE", "EW"]}, {"uuid": "f0627d98-1e81-3a23-95a4-9d11d6e7699c", "title": "Bernstein Adjusts Price Target on Edwards Lifesciences to $74 From $72, Keeps Market Perform Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/bernstein-adjusts-price-target-edwards-111304792.html", "providerPublishTime": 1736421184, "type": "STORY", "relatedTickers": ["EW"]}, {"uuid": "a7c958de-3fcc-3206-85d5-616beb484deb", "title": "Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edwards-lifesciences-present-43rd-annual-120500117.html", "providerPublishTime": 1736251500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/tQMAuB8VZ8OU2paCx.8llg--~B/aD00ODA7dz0zOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/92362f0ba9a065d1733c0c87862372f7", "width": 392, "height": 480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cijVUj1BHeFNe6Wx.mDr_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/92362f0ba9a065d1733c0c87862372f7", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EW"]}]